Shares of Mesoblast Limited (OTCMKTS:MEOBF) were down 6.7% during mid-day trading on Wednesday . The company traded as low as $1.40 and last traded at $1.40. Approximately 1,100 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 57,204 shares. The stock had previously closed at $1.50.
The stock’s 50 day simple moving average is $1.51.
Mesoblast Company Profile (OTCMKTS:MEOBF)
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases.
Featured Article: What are the qualifications of a portfolio manager?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.